These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34959328)

  • 1. Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy.
    Shao Z; Tai W; Qiu Y; Man RCH; Liao Q; Chow MYT; Kwok PCL; Lam JKW
    Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis.
    Shao Z; Chow MYT; Chow SF; Lam JKW
    Pharm Res; 2023 May; 40(5):1073-1086. PubMed ID: 36869245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I, single-dose, dose-escalating study of inhaled dry powder capreomycin: a new approach to therapy of drug-resistant tuberculosis.
    Dharmadhikari AS; Kabadi M; Gerety B; Hickey AJ; Fourie PB; Nardell E
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2613-9. PubMed ID: 23529740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis.
    Shao Z; Tam KK; Achalla VPK; Woon ECY; Mason AJ; Chow SF; Yam WC; Lam JKW
    Int J Pharm; 2024 Apr; 654():123960. PubMed ID: 38447778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Spray-Dried Combination of Capreomycin and CPZEN-45 for Inhaled Tuberculosis Therapy.
    Pitner RA; Durham PG; Stewart IE; Reed SG; Cassell GH; Hickey AJ; Carter D
    J Pharm Sci; 2019 Oct; 108(10):3302-3311. PubMed ID: 31152746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model.
    Garcia-Contreras L; Fiegel J; Telko MJ; Elbert K; Hawi A; Thomas M; VerBerkmoes J; Germishuizen WA; Fourie PB; Hickey AJ; Edwards D
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2830-6. PubMed ID: 17517845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of sequential doses of capreomycin powder for inhalation in guinea pigs.
    Garcia-Contreras L; Muttil P; Fallon JK; Kabadi M; Gerety R; Hickey AJ
    Antimicrob Agents Chemother; 2012 May; 56(5):2612-8. PubMed ID: 22330920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
    Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
    J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Powder, capsule and device: An imperative ménage à trois for respirable dry powders.
    Schoubben A; Blasi P; Giontella A; Giovagnoli S; Ricci M
    Int J Pharm; 2015 Oct; 494(1):40-8. PubMed ID: 26255220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin.
    Fiegel J; Garcia-Contreras L; Thomas M; VerBerkmoes J; Elbert K; Hickey A; Edwards D
    Pharm Res; 2008 Apr; 25(4):805-11. PubMed ID: 17657592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spray-Dried Inhalable Powder Formulations of Gentamicin Designed for Pneumonic Plague Therapy in a Mouse Model.
    Zhu M; Zhang D; Zhang L; Zhao L; Xu L; Wang B; Zhang X; Chen J; Bei Z; Wang H; Zhou D; Yang W; Song Y
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capreomycin oleate microparticles for intramuscular administration: Preparation, in vitro release and preliminary in vivo evaluation.
    Cambronero-Rojas A; Torres-Vergara P; Godoy R; von Plessing C; Sepúlveda J; Gómez-Gaete C
    J Control Release; 2015 Jul; 209():229-37. PubMed ID: 25956458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.
    Sham JO; Zhang Y; Finlay WH; Roa WH; Löbenberg R
    Int J Pharm; 2004 Jan; 269(2):457-67. PubMed ID: 14706257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis.
    Kwok PC; Grabarek A; Chow MY; Lan Y; Li JC; Casettari L; Mason AJ; Lam JK
    Int J Pharm; 2015 Aug; 491(1-2):367-74. PubMed ID: 26151107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
    Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP
    Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.
    Liao Q; Lam ICH; Lin HHS; Wan LTL; Lo JCK; Tai W; Kwok PCL; Lam JKW
    Int J Pharm; 2020 Jun; 584():119444. PubMed ID: 32445908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection.
    Arora S; Haghi M; Loo CY; Traini D; Young PM; Jain S
    Mol Pharm; 2015 Jun; 12(6):2001-9. PubMed ID: 25923171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs.
    Garcia Contreras L; Sung J; Ibrahim M; Elbert K; Edwards D; Hickey A
    Mol Pharm; 2015 Aug; 12(8):2642-50. PubMed ID: 25942002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.